Assignee
SUMMIT CORP PLC
GB·2 granted patents·7 pending applications·4 citations·filing 2008–2014
Top patents by PatentIndex Score
9 records- 0169US8987308B2Compounds for the treatment of Clostridium difficile-associated diseaseSUMMIT CORP PLC·Filed 2012·Granted Mar 24, 2015·2 cites·15 claims
- 0266US9492433B2Pharmaceutical composition for the treatment of Duchenne muscular dystrophySUMMIT CORP PLC·Filed 2014·Granted Nov 15, 2016·2 cites·47 claims
- 0357US2011195929A1Compounds for the treatment of flaviviral infectionsSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 0453US2011015226A1Treatment of Energy Utilization DiseaseSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 0546US2011237538A1Treatment of lysosomal storage disorders and other proteostatic diseasesSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 0645US2014018320A1Treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 0745US2014011782A1Drug combinations for the treatment of duchenne muscular dystrophySUMMIT CORP PLC·Filed 2013·Application pending·0 cites
- 0845US2010317690A1Treatment of protein folding disordersSUMMIT CORP PLC·Filed 2008·Application pending·0 cites
- 0936US2014073801A1Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereofSUMMIT CORP PLC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →